Clinical study on Rhubarb extract tablet in treating simple obesity

Dong-hai Jiao; Xue-min Shen; Ya-ping Gao; Min-xian Chen; Mei-li Wang

doi:10.1007/BF02935106

Your Location：

Home >

Browse articles >

Clinical study on Rhubarb extract tablet in treating simple obesity

OriginalPaper | Updated：2021-08-27

- Clinical study on Rhubarb extract tablet in treating simple obesity
- Clinical study on Rhubarb extract tablet in treating simple obesity
- 中国结合医学杂志（英文版） 2001年7卷第1期页码：33-35
- Affiliations：
  
  Shanghai Municipal Xiangshan TCM Hospital,Shanghai
- Author bio：
- Funds：
- DOI：10.1007/BF02935106
  中图分类号：
- 纸质出版日期：2001，
Scan for full text
Jiao, Dh., Shen, Xm., Gao, Yp. et al. Clinical study on Rhubarb extract tablet in treating simple obesity., CJIM 7, 33–35 (2001). https://doi.org/10.1007/BF02935106

Dong-hai Jiao, Xue-min Shen, Ya-ping Gao, et al. Clinical study on Rhubarb extract tablet in treating simple obesity[J]. Chinese Journal of Integrative Medicine, 2001,7(1):33-35.
Jiao, Dh., Shen, Xm., Gao, Yp. et al. Clinical study on Rhubarb extract tablet in treating simple obesity., CJIM 7, 33–35 (2001). https://doi.org/10.1007/BF02935106 DOI：

Dong-hai Jiao, Xue-min Shen, Ya-ping Gao, et al. Clinical study on Rhubarb extract tablet in treating simple obesity[J]. Chinese Journal of Integrative Medicine, 2001,7(1):33-35. DOI： 10.1007/BF02935106.

摘要

Objective: To study the clinical efficacy of Jinghuang tablet (Rhubarb extract tablet

RET) in treating simple obesity.Methods: Four hundred and seventy-two simple obesity patients were randomly divided into 3 pairs of groups: (1) RET-2 treated group (50 cases): treated with RET vs western drug fenfluramine control group (50 cases). (2) RET treated group vs Chinese patent drug Xiaopangmei (XPM) control group with 50 cases randomly divided into each. (3) RET-1 treated group with 137 cases vs blank control of 135 cases. The aim was to observe markedly effective rate

effective rate and side-effect of RET group and fenfluramine and XPM control groups. At the same time

the slimming efficacy of RET-1 treated group and the blank control group were observed.Results: The slimming effective rate of RET is similar to that of fenfluramine (P < 0. 05)

and better than domestically well accepted slimming Chinese patent drug XPM (P < 0.05). In comparing RET-1 group with blank control group

the difference of weight loss of the 2 groups after 1 week treatment was 0.93 kg on average

which was significant.Conclusion: The efficacy of RET in treating simple obesity was similar to that of fenfluramine

but the side-effect was obviously less than that of fenfluramine

while the markedly effective rate and effective rate in slimming were significantly better than that of XPM.

Abstract